Familial primary biliary cirrhosis in Hiroshima

Journal of Autoimmunity

Volumn 13, Issue 1, 1999, Pages 171-178

  Tsuji, Keiji ^a   Watanabe, Yasuyuki ^a   Van De Water, Judy ^b   Nakanishi, Toshio ^a   Kajiyama, Goro ^a   Parikh Patel, Arti ^b   Coppel, Ross ^c   Gershwin, M Eric ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Anti mitochondrial antibodies; Biliary; Family; Genetic

Indexed keywords

2 OXOACID DEHYDROGENASE; 2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); MITOCHONDRION ANTIBODY; PYRUVATE DEHYDROGENASE COMPLEX;

ADULT; AGED; CONFERENCE PAPER; DISEASE COURSE; FAMILIAL DISEASE; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEALTH CARE SYSTEM; HEREDITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PATHOGENESIS; PEDIGREE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0032766239     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0299     Document Type: Conference Paper

References (57)

1. Kaplan M.M. Primary biliary cirrhosis. New Eng. J. Med. 21:1996;1570-1580.
2. Gershwin M.E., Coppel R.L., Mackay I.R. Primary biliary cirrhosis and mitochondrial autoantigens - insights from molecular biology. Hepatology. 8:1988;147-151.
3. Bassendine M.F., Dewar P.J., James O.F. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut. 26:1985;625-628.
4. Galbraith R.M., Eddleston A.L., Smith M.G., Williams R., McSween R.N., Watkinson G., Dick H., Kennedy L.A., Batchelor J.R. Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Brit. Med. J. 3:1974;604-605.
5. Gores G.J., Moore S.B., Fisher L.D., Powell F.C., Dickson E.R. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology. 7:1987;889-892.
6. Underhill J., Donaldson P., Bray G., Doherty D., Portmann B., Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology. 16:1992;1404-1408.
7. Bach N., Schaffner F. Familial primary biliary cirrhosis. J. Hepatol. 20:1994;698-701.
8. Brind A.M., Bray G.P., Portmann B.C., Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut. 36:1995;615-617.
9. Floreani A., Naccarato R., Chiaramonte M. Prevalence of familial disease in primary biliary cirrhosis in Italy. J. Hepatol. 26:1997;737-740.
10. Walker J.G., Bates D., Doniach D., Ball P.A.J., Sherlock S. Chronic liver disease and mitochondrial antibodies. Brit. Med. J. 1:1972;146-148.
11. Klatskin G., Kantor F.S. Mitochondrial antibody in primary biliary cirrhosis and other diseases. Annals Int. Med. 77:1972;533-541.
12. Chohan M.R. Primary biliary cirrhosis in twin sisters. Gut. 14:1973;213-214.
13. Galbraith R.M., Smith M., Mackenzie R.M., Tee D.E., Doniach D., Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with chronic active hepatitis or primary biliary cirrhosis. New Eng. J. Med. 290:1974;63-69.
14. Tong M.J., Nies K.M., Reynolds T.B., Quismorio F.P. Immunological studies in familial primary biliary cirrhosis. Gastroenterology. 71:1976;305-307.
15. Fagan E.A., Williams R., Cox S. Primary biliary cirrhosis in a mother and daughter. Brit. Med. J. 2:1977;1195.
16. Douglas J.G., Finlayson N.D.C. Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis? Brit. Med. J. 2:1979;419-420.
17. Jaup B.H., Zettergren L.S.W. Familial occurrence of primary biliary cirrhosis associated with hypergammaglobumlinemia in descendants: a family study. Gastroenterology. 78:1980;549-556.
18. Kato Y., Suzuki K., Kumogai M., Nishimura K., Miayamon H., Kobayashi K. Familial primary biliary cirrhosis. Gastroenterology. 75:1981;188-191.
19. Cales P., Calot M., Vogt J.J., Iksman F., Cassigneul J., Vinel J.P., Pascal J.P. Familial autoimmune pathology comprising two cases of primary biliary cirrhosis. Gastroenterol. Clin. Biol. 7:1983;777-784.
20. James S.P., Jones E.A., Schfer D.F., Hoofnagle J.H., Varma R.R., Strober W. Selective immunoglobulin deficiency associated with primary biliary cirrhosis, in a family with liver disease. Gastroenterology. 90:1986;283-288.
21. Chiarantini E., Smorlesi C., Chieca R., Moscarella S., Pasaleva A., Berg P.A. Familial immunological disorders and primary biliary cirrhosis. Ital. J. Gastroenterol. 19:1987;210-212.
22. Chalmers E.A., Chan A., Lam D.C., Holden R.J. Familial PBC and autoimmune thrombocytopenia. Scot. Med. J. 32:1987;152.
23. Manns M.P., Bremm A., Schneider P.M., Notghi A., Gerken G., Prager-Eberle M., Stradmann-Bellinghausen B., Buschenfelde K.H.M.Z., Rittner C. HLA DRw8 and complement C4 deficiency as risk factors for primary biliary cirrhosis. Gastroenterology. 101:1991;1367-1373.
24. Tsuji H., Koichiro M., Kimihiro A., Fuhishima M. Familial primary biliary cirrhosis associated with impaired concanavalian A-induced lymphocyte transformation in relatives. Digest. Dis. Sci. 37:1992;353-360.
25. Harada N., Dohmen K., Itoh H., Ohshima T., Yamamoto H., Nagano M., Iwata Y., Hachisuka K., Ishibashi H. Sibling case of primary biliary cirrhosis associated with polymyositis, vasculitis, and Hashimoto's thyroiditis. Int. Med. 31:1992;289-293.
26. Hamlyn A.N., Macklon A.F., James O. Primary biliary cirrhosis: a geographical clustering and symptomatic onset seasonality. Gut. 24:1983;940-945.
27. Myszor M., James O.F.W. The epidemiology of primary biliary cirrhosis in Northeast England: an increasingly common disease? Quart. J. Med. 75:1990;377-385.
28. Danielsson A., Boqvist L., Uddenfelt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology. 11:1990;458-464.
29. Triger D.R. Primary biliary cirrhosis: an epidemiological study. Brit. Med. J. 281:1980;772-775.
30. Mayberry J., Giggs J., Smart H. Urban clustering of primary biliary cirrhosis. Gut. 27:1986;A1265.
31. Schaffner, F. 1985, Primary biliary cirrhosis, Bockus gastroenterology, J. Berk, W.B. Saunders, Philadelphia, 3150, 3176.
32. Triger D.R., Berg P.A., Rodes J. Epidemiology of primary biliary cirrhosis. Liver. 4:1984;195-200.
33. Surh C.D., Roche T.E., Danner D.J., Ansari A., Coppel R.L., Prindiville T., Dickson E.R., Gershwin M.E. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex. Hepatology. 10:1989;127-133.
34. Surh C.D., Coppel R., Gershwin M.E. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. J. Immunol. 144:1990;3367-3374.
35. Moteki S., Leung P.S.C., Dickson E.R., Van Thiel D.H., Galperin C., Buch T., Alarcon-Segovia D., Kershenobich D., Kawano K., Coppel R.L., Matuda S., Gershwin M.E. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex (OGDC-E2) in primary biliary cirrhosis using recombinant OGDC-E2. Hepatology. 23:1996;436-444.
36. Bach N., Schaffner F. Familial primary biliary cirrhosis. J. Hepatol. 20:1994;698-701.
37. Brind A., Bray G., Portmann B., Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut. 36:1995;615-617.
38. Mori, M. Tamakoshi, A. Kojima, M. Kawamura, T. Ohno, Y. Shiratori, Y. Omata, M. 1997, Nationwide epidemiological survey on intractable hepatic disorder in Japan. In Annual report of research committee on epidemiology of intractable disease Y. Ohno, ed. The Ministry of Health and Welfare in Japan, Japan, pp, 23, 27.
39. Mori, M. Omata, M. Shiratori, Y. Toda, G. Inoue, K. Sato, S. Kojima, M. 1998, Comparison of two nationwide epidemiological surveys on primary biliary cirrhosis, autoimmune hepatitis, and fulminant hepatitis. In Annual report of research committee on epidemiology of intractable disease. Y. Ohno, ed. The Ministry of Health and Welfare of Japan, Japan, pp, 94, 98.
40. Walker J.G., Bates D., Doniach D., Ball P.A.J., Sherlock S. Chronic liver disease and mitochondrial antibodies: a family study. Brit. Med. J. 1:1972;146-148.
41. James O.F., Myszor M. Epidemiology and genetics of primary biliary cirrhosis. Prog. Liver Dis. 9:1990;523-536.
42. Bach N., Schaffner F. Prevalence of primary biliary cirrhosis in family members of affected patients. Gastroenterology. 102:1991;A776.
43. Galbraith R.M., Eddleston A.L.W.F., Smith M.G.M., Williams R., McSween R.N., Watkinson G., Dick H., Kennedy L.A., Batchelor J.R. Histocompatibility antigens in autoimmune chronic hepatitis and primary biliary cirrhosis. Brit. Med. J. 3:1974;604-605.
44. Bassendine M.F., Dewar P.J., James O.F.W. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut. 26:1985;625-628.
45. Ercilla G., Pares A., Arriaga F. Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens. 14:1979;449-452.
46. Miyamori H., Kato Y., Kobayashi K., Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion. 26:1983;213-217.
47. Underhill J., Donaldson P., Bray G., Doherty D., Portmann B., Williams R. Susceptibility to primary biliary cirrhosis is associated with HLA-DR8-DQB1*402 haplotype. Hepatology. 16:1992;1404-1408.
48. Onishi S., Sakamaki T., Maeda T. DNA typing of HLA class II genes DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J. Hepatology. 21:194;1053-1060.
49. Gregory W.L., Mehal W., Dunn A.N., Cavanagh G., Chapman R., Fleming K.A., Daly A.K., Idle J.R., James O.F., Bassendine M.F. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Queensland J. Med. 86:1993;393-399.
50. Terasaki, P.I. 1971, HL-A histocompatibility determinants, Disease-a-month. Year Book Medical Publishers, Chicago, 1, 34.
51. Ito K., Nakagawa J., Ikehara K. Histocompatibility antigens in chromic active hepatitis and primary biliary cirrhosis. Jap. J. Clin. Med. 36:1978;111-118.
52. Surh C.D., Cooper A.E., Coppel R.L., Leung P., Ahmed A., Dickson R., Gershwin M.E. The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology. 8:1988;290-295.
53. Joplin R., Lindsay J.G., Johnson G.D., Strain A., Neuberger J. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet. 339:1992;93-94.
54. Ballardini G., Mirakian R., Bianchi F.B., Pisi E., Doniach D., Bottazzo G.F. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet. 2:1984;1009-1013.
55. Burroughs A.K., Butler P., Sternberg M.J., Baum H. Molecular mimicry in liver disease. Nature. 358:1992;377-378.
56. Feizi T., Naccarato R., Sherlock S., Doniach D. Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin. Exper. Immunol. 10:1972;609-622.
57. Caldwell S.H., Leung P.S.C., Spivey J.R., Prindiville T., De Medina M., Saicheur T., Rowley M., Reddy K.R., Coppel R., Jeffers L.J., Mackay I.R., Schiff E.R., Gershwin M.E. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Hepatology. 16:1992;899-905.